
Featured
FDA Approves MDMA-Assisted Psychotherapy for Severe PTSD Following Landmark Phase 3 MAPS Trials
The FDA has approved MDMA-assisted psychotherapy for severe PTSD based on Phase 3 MAPS trial data. The treatment combines the neuroplastic and empatho...
Read Full Story →


